|
AbbVie announced it has reached a deal to acquire the biopharmaceutical company Pharmacyclics in a $21 billion deal -- a mix of cash and stock for $261.25 a share.
|
피드 구독하기:
댓글 (Atom)
Newsletter & science, newspaper, software, hardware, do-it-yourself, startup
|
AbbVie announced it has reached a deal to acquire the biopharmaceutical company Pharmacyclics in a $21 billion deal -- a mix of cash and stock for $261.25 a share.
|
댓글 없음:
댓글 쓰기